Besides this encouraging case, we also find a surprising case concerning Lansoprazole, a drug that targets MAPT, a gene shared by the multimorbidity of E66 (Obesity) and J84 (Other interstitial pulmonary diseases). Here, MAPT is linked to obesity disorder.